BridgeBio Pharma (BBIO) Competitor Comparison
We are evaluating the key criteria listed to compare BridgeBio Pharma (BBIO) against its competitors in the Biotechnology industry.
Market Capitalization
30 / 368Gross Profits
53 / 278Total Revenue
186 / 300EBITDA
324 / 337Free Cashflow
339 / 352Quick Ratio
179 / 357Earnings per Share
245 / 359Dividend yield
0 / 6Total Cash
55 / 358Performance 3 years
161 / 368Performance 5 years
128 / 368Performance 10 years
114 / 368Linearity 3 years
116 / 368Linearity 5 years
16 / 368Linearity 10 years
2 / 368Total Rank
42 / 368Dividend Rank
72 / 368Valuation Rank
192 / 368Piotroski Rank
242 / 368Muliplier Rank
299 / 368Performance 3 years - BBIO ranking 161 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.